dc.identifier.citation |
Al Saadany, H., Hussein, M., Gaber, R., & Zaytoun, H. (2016). Th-17 cells and serum IL-17 in rheumatoid arthritis patients: Correlation with disease activity and severity. Egypt Rheumatol, 38, 1–7. Aragane, Y., Kulms, D., Metze, D., Wilkes, G., Pöppelmann, B., Luger, T. A., & Schwarz, T. (1998). Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) inde- pendently of its ligand CD95L. The Journal of Cell Biology, 140, 171–182. Asadullah, K., Sterry, W., Stephanek, K., Jasulaitis, D., Leupold, M., Audring, H., . . . Döcke, W. D. (1998). IL-10 is a key cytokine in psoriasis. Proof of Principle by IL-10 Therapy: A New Therapeutic Approach. J Clin Invest, 101, 783–794. Baghdadi, M., Umeyama, Y., Hama, N., Kobayashi, T., Han, N., Wada, H., & Seino, K. I. (2018). Interleukin-34, a comprehensive review. Journal of Leukocyte Biology, 104, 931–951. Barr, R. M., Walker, S. L., Tsang, W., Harrison, G. I., Ettehadi, P., Greaves, M. W., & Young, A. R. (1999). Suppressed alloanti- gen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin. The Journal of Investigative Dermatology, 112, 692–698. Boehncke, W. H., & Schön, M. P. (2015). Psoriasis. Lancet, 386, 983–994. Boonstra, A., Barrat, F. J., Crain, C., Heath, V. L., Savelkoul, H. F., & O’Garra, A. (2001). 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. Journal of Immunology (Baltimore, Md.: 1950), 167, 4974–4980. Calzavara-Pinton, P. G., Sala, R., Arisi, M., Rossi, M. T., Venturini, M., & Ortel, B. (2013). Synergism between nar- rowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis. The British Journal of Dermatology, 169, 130–136. Greter, M., Lelios, I., Pelczar, P., Hoeffel, G., Price, J., Leboeuf, M., . . . Becher, B. (2012). Stroma derived IL-34 controls the develop- ment and maintenance of langerhans cells and maintenance of microglia. Immunity, 37, 1050–1060. Grine, L., Tochtermann, G., Lapeere, H., Maes, N., Hofbauer, G. F. L., Vervaet, M., & Lambert, J. (2020). Comparison of personality traits among patients with psoriasis, atopic dermatitis, and stress: A pilot study. Dermatology, 5, 1–5. Ibrahim, A. M., Labib, Z. T., Nofal, A. A., & Boghdadi, G. S. (2015). Interleukin 23 and interleukin17 in psoriasis, atopic dermatitis and lichen planus: A serological study. Zagazig University Medical Journal, 21, 31–37. Işık, S., Sılan, F., Kılıç, S., Hız, M. M., Ögretmen, Z., & Özdemir, Ö. (2016). 308G/A and 238G/A polymorphisms in the TNF-a gene may not contribute to the risk of arthritis among Turkish psoriatic patients. Egypt Rheumatol, 38, 313–317. Johnson-Huang, L. M., Suárez-Fariñas, M., Sullivan- Whalen, M., Gilleaudeau, P., Krueger, J. G., & Lowes, M. A. (2010). Effective narrow-band UVB radia- tion therapy suppresses the IL-23/IL-17 axis in normal- ized psoriasis plaques. Journal of Investigative Dermatology, 130, 2654–2663. Kulms, D., Pöppelmann, B., Yarosh, D., Luger, T. A., Krutmann, J., & Schwarz, T. (1999). Nuclear and cell mem- brane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proceedings of the National Academy of Sciences of the United States of America, 96, 7974–7979. Lapolla, W., Yentzer, B. A., Bagel, J., Halvorson, C. R., & Feldman, S. R. (2011). A review of phototherapy protocols for psoriasis treatment. Journal of the American Academy of Dermatology, 64, 936–949. Lee, E., Koo, J., & Berger, T. (2014). UVB phototherapy and skin cancer risk: A review of the literature. International Journal of Dermatology, 44, 355–360. Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., . . . Krueger, J. G. (2008). Psoriasis vulgaris lesions contain discrete populations of T1 and T17 T cells. Journal of Investigative Dermatology, 128, 1207–1211. McGinley, A. M., Sutton, C. E., Edwards, S. C., Leane, C. M., DeCourcey, J., Teijeiro, A., . . . Mills, K. H. G. (2020). Interleukin-17A serves a priming role in autoimmunity by recruiting IL-1β-producing myeloid cells that promote pathogenic T cells. Immunity, S1074–7613(20)30029–7 doi:10.1016/j.immuni.2020.01.002 Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., . . . Bhushan, R. (2008). Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1 Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. Journal of the American Academy of Dermatology, 58, 826–850. Menter, A., & Griffiths, C. E. (2007). Current and future man- agement of psoriasis. Lancet, 370, 272–284. Moon, S. J., Hong, Y. S., Ju, J. H., Kwok, S. K., Park, S. H., & Min, J. K. (2013). Increased level of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titres in patients with rheumatoid arthritis. The Journal of Rheumatology, 40, 1842–1849. Ozawa, M., Ferenczi, K., Kikuchi, T., Cardinale, I., Austin, L. M., Coven, T. R., . . . Krueger, J. G. (1999). 312-nanometer ultra- violet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. The Journal of Experimental Medicine, 189, 711–718. |
en_US |